|
|
 |
Heron Shanghai Pharmaceutical Science and Technology Co., Ltd.
|
|
|
| |
|
|
Founded in 2013, Heron Pharma is a pharmaceutical company adhering to an innovation-driven and product differentiation strategy. lt possesses world-leading research and development technology for active vitamin D derivatives, NCEs and first generics. The bulk production of active vitamin D derivative drugs can be provided over the world, including Alfacalcidol, Calcipotriol, Calcifediol, Calcitriol, Eldecalcitol, Doxercalciferol, Maxacalcitol, Paricalcitol, Tacalcitol, etc.
Over the past decade, 8 FDFs have been successfully commercialized in China, including the first generics of Tacalcitol Ointment and Regadenoson Injection. And 2 products Calcitriol Soft Capsules and Ketorolac Tromethamine Injection have been involved in the centralized purchasing of the National Healthcare Security Bureau.
|
[ Selling Categories ]
|
[ keyword ]
|
Registration Date |
2025/04/11 (Year/Month/Date) |
Buyer / Seller in EC21 |
Seller |
Business Type |
Trading Company |
Year established |
2019 |
Employees total |
6 - 10 |
Annual revenue |
USD 500,001 - 1,000,000 |
|
Contact Information |
 |
|
Company |
Heron Shanghai Pharmaceutical Science and Technology Co., Ltd. |
Address |
Room 413 Block B, No. 2419 Hunan Road, Pudong New Area District Shanghai Alabama 200120 United States |
Phone |
86 - 21 - 58479758 |
Homepage |
https://www.heronpharma-sh.com/ |
Contact |
James Shao
|
|
|
|
| |
|
|
|